Dow Down 1.03% Nasdaq Down 0.99%

Dyax Corp. (DYAX)

-NasdaqGM
10.02 Down 0.10(0.99%) 11:50AM EDT - Nasdaq Real Time Price
Prev Close:10.12
Open:10.16
Bid:10.07 x 400
Ask:10.09 x 700
1y Target Est:12.36
Beta:0.93
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:9.90 - 10.40
52wk Range:6.05 - 11.01
Volume:245,453
Avg Vol (3m):1,006,520
Market Cap:1.36B
P/E (ttm):N/A
EPS (ttm):-0.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXDown 0.99%1.36B
SHPGDown 0.44%50.41B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.19
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-2.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback